180 related articles for article (PubMed ID: 27458212)
1. Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs.
Wickham KS; Baresel PC; Marcsisin SR; Sousa J; Vuong CT; Reichard GA; Campo B; Tekwani BL; Walker LA; Rochford R
Antimicrob Agents Chemother; 2016 Oct; 60(10):5906-13. PubMed ID: 27458212
[TBL] [Abstract][Full Text] [Related]
2. Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.
Nanayakkara NP; Tekwani BL; Herath HM; Sahu R; Gettayacamin M; Tungtaeng A; van Gessel Y; Baresel P; Wickham KS; Bartlett MS; Fronczek FR; Melendez V; Ohrt C; Reichard GA; McChesney JD; Rochford R; Walker LA
Antimicrob Agents Chemother; 2014 Aug; 58(8):4737-44. PubMed ID: 24913163
[TBL] [Abstract][Full Text] [Related]
3. Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.
Bastiaens GJH; Tiono AB; Okebe J; Pett HE; Coulibaly SA; Gonçalves BP; Affara M; Ouédraogo A; Bougouma EC; Sanou GS; Nébié I; Bradley J; Lanke KHW; Niemi M; Sirima SB; d'Alessandro U; Bousema T; Drakeley C
PLoS One; 2018; 13(1):e0190272. PubMed ID: 29324864
[TBL] [Abstract][Full Text] [Related]
4. Model-based assessment of the safety of community interventions with primaquine in sub-Saharan Africa.
van Beek SW; Svensson EM; Tiono AB; Okebe J; D'Alessandro U; Gonçalves BP; Bousema T; Drakeley C; Ter Heine R
Parasit Vectors; 2021 Oct; 14(1):524. PubMed ID: 34627346
[TBL] [Abstract][Full Text] [Related]
5. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
Valencia SH; Ocampo ID; Arce-Plata MI; Recht J; Arévalo-Herrera M
Malar J; 2016 May; 15(1):291. PubMed ID: 27225440
[TBL] [Abstract][Full Text] [Related]
6. Modelling primaquine-induced haemolysis in G6PD deficiency.
Watson J; Taylor WR; Menard D; Kheng S; White NJ
Elife; 2017 Feb; 6():. PubMed ID: 28155819
[TBL] [Abstract][Full Text] [Related]
7. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
[TBL] [Abstract][Full Text] [Related]
8. Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
Kheng S; Muth S; Taylor WR; Tops N; Kosal K; Sothea K; Souy P; Kim S; Char CM; Vanna C; Ly P; Ringwald P; Khieu V; Kerleguer A; Tor P; Baird JK; Bjorge S; Menard D; Christophel E
BMC Med; 2015 Aug; 13():203. PubMed ID: 26303162
[TBL] [Abstract][Full Text] [Related]
9. Consideration of ethics in primaquine therapy against malaria transmission.
Baird JK; Surjadjaja C
Trends Parasitol; 2011 Jan; 27(1):11-6. PubMed ID: 20846906
[TBL] [Abstract][Full Text] [Related]
10. Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.
Taylor WR; Naw HK; Maitland K; Williams TN; Kapulu M; D'Alessandro U; Berkley JA; Bejon P; Okebe J; Achan J; Amambua AN; Affara M; Nwakanma D; van Geertruyden JP; Mavoko M; Lutumba P; Matangila J; Brasseur P; Piola P; Randremanana R; Lasry E; Fanello C; Onyamboko M; Schramm B; Yah Z; Jones J; Fairhurst RM; Diakite M; Malenga G; Molyneux M; Rwagacondo C; Obonyo C; Gadisa E; Aseffa A; Loolpapit M; Henry MC; Dorsey G; John C; Sirima SB; Barnes KI; Kremsner P; Day NP; White NJ; Mukaka M
BMC Med; 2018 Jan; 16(1):11. PubMed ID: 29347975
[TBL] [Abstract][Full Text] [Related]
11. The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians.
Dysoley L; Kim S; Lopes S; Khim N; Bjorges S; Top S; Huch C; Rekol H; Westercamp N; Fukuda MM; Hwang J; Roca-Feltrer A; Mukaka M; Menard D; Taylor WR
BMC Infect Dis; 2019 Mar; 19(1):250. PubMed ID: 30871496
[TBL] [Abstract][Full Text] [Related]
12.
Pett H; Bradley J; Okebe J; Dicko A; Tiono AB; Gonçalves BP; Stone W; Chen I; Lanke K; Neuvonen M; Mustaniemi AL; Eziefula AC; Gosling R; D'Alessandro U; Drakeley C; Niemi M; Bousema T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383656
[TBL] [Abstract][Full Text] [Related]
13. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of primaquine and its metabolites in African males.
Chotsiri P; Mahamar A; Diawara H; Fasinu PS; Diarra K; Sanogo K; Bousema T; Walker LA; Brown JM; Dicko A; Gosling R; Chen I; Tarning J
Malar J; 2024 May; 23(1):159. PubMed ID: 38773528
[TBL] [Abstract][Full Text] [Related]
15. Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
Rochford R; Ohrt C; Baresel PC; Campo B; Sampath A; Magill AJ; Tekwani BL; Walker LA
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17486-91. PubMed ID: 24101478
[TBL] [Abstract][Full Text] [Related]
16. Association of G6PD status and haemolytic anaemia in patients receiving anti-malarial agents: a systematic review and meta-analysis.
Nelwan EJ; Shakinah S; Pasaribu A
Malar J; 2023 Mar; 22(1):77. PubMed ID: 36872344
[TBL] [Abstract][Full Text] [Related]
17. Glucose-6-phosphate dehydrogenase deficiency A- variant in febrile patients in Haiti.
Carter TE; Maloy H; von Fricken M; St Victor Y; Romain JR; Okech BA; Mulligan CJ
Am J Trop Med Hyg; 2014 Aug; 91(2):412-4. PubMed ID: 24891465
[TBL] [Abstract][Full Text] [Related]
18. Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial.
Chen I; Diawara H; Mahamar A; Sanogo K; Keita S; Kone D; Diarra K; Djimde M; Keita M; Brown J; Roh ME; Hwang J; Pett H; Murphy M; Niemi M; Greenhouse B; Bousema T; Gosling R; Dicko A
J Infect Dis; 2018 Mar; 217(8):1298-1308. PubMed ID: 29342267
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
[TBL] [Abstract][Full Text] [Related]
20. The effect of single low-dose primaquine treatment for uncomplicated Plasmodium falciparum malaria on hemoglobin levels in Ethiopia: a longitudinal cohort study.
Habtamu K; Getachew H; Abossie A; Demissew A; Tsegaye A; Degefa T; Wang X; Lee MC; Zhou G; Kibret S; King CL; Kazura JW; Petros B; Yewhalaw D; Yan G
Res Sq; 2024 Mar; ():. PubMed ID: 38559068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
